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Abstract 
Objective: To measure the ability of a new bioscore to diagnose sepsis in a general critical care population.
Methods: The study was done at an intensive care unit (ICU) from April to December 2012. Demographic and clinical 
patient information were recorded on admission to the ICU with blood samples taken for C-reactive protein (CRP), 
procalcitonin (PCT), interleukin-6, white blood cell count, as well as body temperature, age and the sepsis-related 
organ failure (SOFA) score. These parameters were used to create a scoring system. The scoring system then under-
went analysis by univariate analysis and multivariate logistic regression analysis to identify which of these clinical 
parameters were statistically different in septic versus non-septic patients. The bioscore was then tested in a receiver 
operator characteristic curve to determine statistical significance of the scoring systems ability to predict sepsis. 
Finally, a bioscore cutoff value was defined to provide a level for sepsis diagnosis.
Results: Three hundred patients were enrolled, of which 107 patients were septic and 193 patients were non-septic. 
Univariate logistic regression showed that age, gender, CRP, PCT and SOFA were risk factors for occurrence of sepsis. 
Multivariate analysis revealed CRP (AUC 0.729, 95 % CI 0.671–0.787, P < 0.001), PCT (AUC 0.711, 95 % CI 0.652–0.770, 
P < 0.001) and SOFA (AUC 0.670, 95 % CI 0.607–0.733, P < 0.001) to be statistically significant. The combination of these 
values in the bioscore had an AUC of 0.790 (95 % CI 0.739–0.834, P < 0.001). A bioscore of ≥2.65 was considered to be 
statistically significant in making a positive diagnosis of sepsis.
Conclusions: This bioscore using CRP, PCT and SOFA score may potentially be used in the future to help identify 
septic patients earlier, improving their access to timely treatment modalities.
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Background
Sepsis and septic shock are pathological conditions 
impacting a large proportion of patients admitted to 
the ICU, and these patients unfortunately have poor 
outcomes [1]. Sepsis results from a dysregulated host 
response to infection leading to uncontrolled inflamma-
tion and organ dysfunction and potentially a hypotensive 
state known as septic shock [2]. This clinical scenario falls 
under the multiple organ dysfunction syndrome [3].
Early diagnosis and direct appropriate therapy within 
the first hours of hospital admission has been shown 
to have beneficial effects with respect to patient out-
come [4]. Furthermore, diagnostic and treatment delay 
prolongs hospital length of stay and increases health-
care costs [5, 6]. As a result, the availability of an effi-
cient biomarker/evaluation system would be crucial to 
help diagnose sepsis quickly. To be useful, a biomarker 
should be characterized by its “capacity to provide timely 
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information beyond that which is readily available from 
routine physiologic data and clinical examination” [7].
Several bloodstream biomarkers in sepsis have been 
previously investigated [8], including PCT and CRP [9]. 
Sepsis-induced cytokines promote the production of 
PCT, which is typically secreted by C cells of the thy-
roid in response to hypercalcemia. Similarly, CRP is an 
acute-phase reactant, synthesized by the liver, mainly in 
response to IL-6. IL-6 is a cytokine that generates an ini-
tial response to injury or infection; its levels rise signifi-
cantly during early sepsis, and for this reason, it has been 
used for sepsis diagnosis and patient outcome prediction 
[10, 11]. Despite their common use, all these biomarkers 
suffer individual applicability limitations, including lack 
of sepsis specificity [12]. Another approach has been to 
consider a combination of markers and clinical parame-
ters, known as a bioscore. Recently, Gibot et al. [13] dem-
onstrated high diagnostic performance by a bioscore that 
combined the intensity of CD64 expression on polymor-
phonuclear cells (PMN CD64 index) together with PCT 
and the soluble triggering receptor expressed on myeloid 
cells-1 (sTREM-1) serum levels. However, while PCT 
measurement is widely and easily performed, sTREM-1 
determination (by an ELISA assay) and CD64 assessment 
(by flow cytometery) is not routinely available in all hos-
pitals, giving some limitations to this approach.
We hypothesized that by combining the common 
clinical biomarkers CRP, PCT and IL-6 with other clini-
cal information, such as WBC, body temperature, age 
and gender, and the SOFA score in an extended bioscore 
(e-BS), we might be able to increase sensitivity and speci-
ficity of the combination of these tools for sepsis diagno-
sis. The aim of this investigation was to evaluate the value 
of these individual markers and to investigate whether 




This prospective study was performed in the ICU of 
a Nanjing Zhong-Da Hospital from April to Decem-
ber 2012. The protocol was approved by the local 
Institutional Ethics Committee (Approval Number: 
2012ZD11KY08.0) in accordance with the ethical stand-
ards of the Declaration of Helsinki. Patients admitted into 
the ICU were enrolled in this study following informed 
consent from the patient or their guardian.
Patients
Inclusion criteria were: (1) ICU admission; (2) signed 
informed consent from the patient or their guardian; (3) 
≥18 years of age. Patients were excluded from enrollment 
if they had been hospitalized or received antibiotics in 
the preceding 2 weeks, or if it was an ICU re-admission.
All eligible patients were treated by the attending phy-
sician according to normal clinical practice. If an infec-
tion was suspected or documented, samples of organic 
fluids were collected for microbiologic cultural tests and 
antimicrobial therapy was prescribed according to the 
ICU practice and guidelines [14] without any interven-
tion by the researchers.
Sepsis was clinically  defined as a diagnosed infection 
and at least two of four systemic inflammatory response 
syndrome (SIRS) criteria [15] which include: (a) body 
temperature >38 or <36  °C, (b) heart rate >90  beats/
min, (c) respiratory rate >20 breaths/min or an arterial 
partial pressure of carbon dioxide < 4.3 kPa (32 mmHg), 
(d) white blood cell count >12,000 or <4000/mm3, or the 
presence of >10  % immature neutrophils. The infection 
was defined on the basis of  infection sites, clinical fea-
tures, clinical microbiology and imaging tests. Two inten-
sive care physicians were asked to retrospectively and 
independently analyze the clinical documentation for 
each patient, signs, symptoms and recent medical history 
to make the diagnosis of sepsis.
Data collection
The acquired dataset included the patients’ demographic 
information, reason for admission, department of origin, 
infection site, blood culture results and laboratory char-
acteristics. The patients were subsequently followed for 
28 days for mortality.
Acute physiology and chronic health evaluation II 
(APACHE II) and sepsis-related organ failure assess-
ment (SOFA) scores were calculated using data from 
the first 24 h after admission. Clinically significant WBC 
count was defined as WBC <4000 cells/µL (leukopenia) 
or >12,000 cells/µL (leukocytosis). Clinically significant 
body temperature was defined as <36  °C (hypothermia) 
or >38 °C (hyperthermia) [14, 15]. We also recorded the 
ICU and hospital length of stay.
Measurement of CRP, PCT and IL‑6
Within 12 h after ICU admission, 5–10 mL of blood was 
sampled for CRP, PCT and IL-6 measurements. CRP 
concentrations were measured in a serum sample, using a 
turbidimetric immunoassay test (BNII, Siemens Health-
care Diagnostic, Germany). PCT concentrations were 
assessed in a serum sample, using an immunoassay with 
a sandwich technique and a chemiluminescent detection 
system, while IL-6 concentrations using a turbidimetric 
immunoassay test (Roche Elecsys® and MODULAR® 
E170, Switzerland). CRP, PCT and IL-6 were transformed 
into categorical score values (Additional file 1: Table S1).
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Statistics and the scoring system
Normality distribution for quantitative variables was 
tested by the Kolmogorov–Smirnov test (P  >  0.10). For 
categorical variables, Chi-square test, Fisher’s exact test 
or McNemar test were applied as appropriate. Compari-
son of continuous variables between the two groups was 
conducted with Student’s t test or Mann–Whitney U test 
depending on Gaussian distribution. To compare data 
from three or more patient groups, we applied the one-
way analysis of variance (ANOVA), and, when indicated, 
the Student–Newmann–Keuls method was used as a 
post hoc test. Sensitivity and specificity were computed 
for all biomarker assays.
Logistic regression was used according to the presence 
or absence of sepsis and death as dependent variables to 
calculate the corresponding regression coefficients (using 
round numbers). The bioscore system was analyzed 
for the area under the curve, and the subsequent ROC 
curves were used to evaluate the prognostic value. The 
Youden index was applied to set the cutoffs and com-
pared between the combined evaluation method and sin-
gle evaluation methods.
Normally distributed data are expressed as mean ± SD, 
while non-normal distributed as median [25th–75th 
IQR]. All statistical analyses were performed using SPSS 
19.0 software (IBM SPSS, USA); two-tailed P values <0.05 
were considered statistically significant.
Results
Baseline data
Three hundred consecutive patients were included. The 
entire population characteristics including infection and 
organism findings of septic populations are shown in 
Table  1 and Additional file  1: Table S2. Specifically, we 








Age (years) 64 ± 18 69 ± 15 61 ± 19 <0.001
Male sex, n (%) 173 (58) 74 (69) 99 (51) <0.001
Body temperature, n (%) 0.03
 <36 or >38 °C 97 (32.3 %) 43 (40.2) 54 (28.0)
 36–38 °C 203 (67.7 %) 64 (59.8) 139 (72.0)
APACHE II score 17 ± 8 19 ± 7 16 ± 8 0.002
SOFA score 6.8 ± 3.5 8.2 ± 3.5 6.1 ± 3.2 <0.001
Admission department—no. (%)
 Emergency room 86 (28.7) 39 (36.4) 47 (24.4) 0.026
 Surgical wards 164 (54.7) 32 (29.9) 132 (68.4) <0.001
 Without surgical procedure 5 (1.7) 3 (2.8) 2 (1.0) 0.252
 With surgical procedure 159 (53) 29 (27.1) 130 (67.3) <0.001
 Medical wards 50 (16.7) 36 (33.6) 14 (7.2) <0.001
Pathology of admission—no. (%)
 Acute pancreatitis 2 (0.7) 1 (0.9) 1 (0.5) 1.0
 Intracerebral hemorrhage 32 (10.7) 8 (7.5) 24 (12.4) 0.183
 Cardiac arrest 8 (2.7) 2 (1.9) 6 (3.1) 0.519
 Trauma 17 (5.7) 3 (2.8) 15 (7.8) <0.001
 Acute myocardial infarction 10 (33.3) 4 (3.7) 6 (3.1) 0.777
 High-risk surgery 130 (43.3) 0 130 (67.4)
  Cardiac surgery 51 (17.0) 0 51 (26.4)
  Non-cardiac surgery 79 (26.3) 0 79 (40.9)
 Sever sepsis 79 (26.3) 79 (73.8) 0
 Other 22 (7.3) 10 (9.3) 12 (6.1) 0.296
CRP 37.25 (8.79–87.13) 63.8 (32.3–114) 21.8 (5.20–60.55) <0.001
PCT 0.66 (0.16–3.13) 1.79 (0.57–8.95) 0.38 (0.11–1.54) <0.001
IL-6 125.2 (52.5–463.3) 124.8 (43.9–418.3) 125.6 (54.5–479.9) 0.97
Length of ICU stay—no. of days 5 [2–10] 8 [4–14] 3 [1–8] <0.001
Length of hospital stay—no. of days 19 [10–28] 23 [13–32] 18 [9–26] 0.005
28-day mortality—no. (%) 75 (25) 32 (30) 43 (22) 0.144
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collected data on age, gender, core body temperature, 
WBC, PCT, CRP, IL-6 and calculated a SOFA score. Of 
note, 107 (35.7 %) patients (septic population) were septic, 
which included the subgroups of sepsis (n =  28, 9.3  %), 
severe sepsis (n  =  41, 13.7  %) or septic shock (n  =  38, 
12.7 %) patients. The other 193 patients were not septic.
Diagnostic value of the scoring system
Univariate analysis of the measured raw patient parame-
ters using a ROC curve showed that CRP, PCT and SOFA 
were significant for the diagnosis of sepsis (Fig. 1a). The 
AUCs were 0.729, 0.737 and 0.671, respectively (Table 2). 
The analysis revealed that clinical laboratory values of 
21.1, 0.4475 and 6, respectively, were cutoff points that 
helped make the diagnosis of sepsis. However, given 
that the AUC values were low, we felt using the raw 
laboratory values would not accurately be able to pre-
dict a sepsis diagnosis. Therefore, we used the measured 
parameters to define a categorical-based scoring system 
in an attempt to better delineate syndrome clusters. 
In order to define the scoring system (bioscore), each 
measured clinical variable (using a rounded number) 
was converted into categorical values as a final weighted 
value, as shown in Additional file 1: Table S3. Subsequent 
univariate analysis of these ordinal values indicated that 
age, gender, PCT, CRP and SOFA were significantly cor-
related with occurrence of sepsis according to the score 
in Additional file 1: Table S1 (Table 3). However, we did 
not find WBC, body temperature and IL-6 had diagnostic 
value in recognizing sepsis. Then, multivariate analysis by 
logistic regression using the presence or absence of sep-
sis as a dependent variable and the parameters identified 
by univariate analysis found statistical significance of age, 
gender, CRP, PCT and SOFA (Table 3). 
To further refine the scoring system, we eliminated age 
and gender as we felt these parameters were less specific 
to predicting when a patient was truly septic. Therefore, 
we analyzed the total bioscore of each patient (using 
only CRP, PCT and SOFA score) on a ROC. When the 
bioscore was plotted for analysis by ROC curve (Fig. 1b), 
the AUC was 0.790 (95  % CI 0.739–0.834, P  <  0.001) 
with a cutoff value of 2.65 suggesting a diagnosis of sep-
sis above this value. The sensitivity and specificity of the 
scoring system were 78.5 and 70  %, respectively, with a 
positive likelihood ratio of 2.61 and negative likelihood 
ratio of 0.31, respectively (Table 2).
Diagnostic value of the scoring system in subgroup 
populations
Surgical procedures impact physiologic parameters and, 
therefore, sought to evaluate the predictive ability of this 
Fig. 1 Diagnostic values for sepsis of clinical variables estimated by 
receiver operating curve (ROC) analysis. a Area under the curve (AUC) 
for a null hypothesis was 0.5. AUC for C-reactive protein (CRP) was 
0.729 (95 % CI 0.675–0.779, P < 0.001), procalcitonin (PCT) 0.737 (95 % 
CI 0.683–0.786, P < 0.001), interleukin-6 (IL-6) 0.511 (95 % CI 0.452–
0.570, P = 0.760), white blood cells (WBC) 0.472 (95 % CI 0.400–0.545, 
P = 0.426), body temperature 0.468 (95 % CI 0.398–0.539, P = 0.362) 
and sepsis-related organ failure assessment (SOFA) 0.671 (95 % CI 
0.615–0.714, P < 0.001). b For calculated score: Area under the curve 
(AUC) for a null hypothesis was 0.5. AUC for calculated score was 
0.790 (95 % CI 0.739–0.834, P < 0.001)
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bioscore in a subset of surgical patients. In a subgroup of 
patients that underwent surgical procedures (n  =  160), 
univariate analysis determined significance for only CRP 
and PCT in sepsis diagnosis (Fig. 2a; Table 2). The AUC 
of CRP and PCT was 0.697 and 0.698, respectively. When 
the previously determined bioscore system was evalu-
ated by ROC curve analysis in this patient subgroup, the 
AUC was 0.745 (95 % CI 0.670–0.810, P < 0.001) with a 
sensitivity and specificity of 82.8 and 63.4 %, respectively. 
The scoring system, which contained more contributing 
measurable data points, was higher than any of the indi-
vidual parameters (Fig. 2b; Table 2).
In the non-surgically treated patients (n  =  140), 
CRP, PCT and SOFA score had significant diagnostic 
value in diagnosing sepsis (Fig. 2c; Table 2). When the 
scoring system was evaluated by ROC curve analysis 
in this patient subgroup, the AUC was 0.836 (95  % 
CI 0.764–0.893, P < 0.001), which was better at iden-
tifying sepsis than any of the individual parameters 
(Fig. 2d; Table 2).
In the newly hospitalized patient subgroup (n  =  86), 
univariate analysis revealed that CRP, PCT and SOFA 
were statistically significant in diagnosing sepsis (Fig. 2e; 
Table 2). Bioscores in this subgroup gave an AUC of 0.896 
(95 % CI 0.812–0.952, P < 0.001) also showing a greater 
ability at identifying sepsis than any individual parameter 
(Fig. 2f; Table 2).
Risk factors for the 28‑day mortality
Univariate analysis detected age, body temperature, 
SOFA score and IL-6 demonstrating significance asso-
ciation with the 28-day mortality (OR 1.017, 95  % CI 
1.001–1.033, P = 0.038; OR 1.214, 95 % CI 1.002–1.471, 
P = 0.048; OR 1.261, 95 % CI 1.160–1.371, P < 0.001; OR 
1.010, 95 % CI 1.001–1.017, P = 0.045, respectively). Mul-
tivariate logistic regression analysis showed that only age 
and SOFA were independently associated with 28-day 
mortality (OR 1.022, 95 % CI 1.003–1.041, P = 0.024; OR 
1.263, 95 % CI 1.148–1.389, P < 0.001) (Table 4). Cox and 
Snell R2 was 0.144, and Nagelkerke R2 was 0.215.
Table 2 Diagnostic value of each parameter in sepsis
Variables AUC P value Sensitivity Specificity +LR −LR
All patients
 SOFA 0.671 <0.001 66.4 61.7 1.73 0.55
 CRP 0.729 <0.001 90.7 49.7 1.80 0.19
 PCT 0.737 <0.001 82.9 53.9 1.80 0.32
 IL-6 0.511 0.760 28.2 78.7 1.32 0.91
 Score 0.790 <0.001 78.5 70.0 2.61 0.31
Surgical patients
 SOFA 0.587 0.150 51.7 62.6 1.38 0.77
 CRP 0.697 <0.001 89.7 45.0 1.63 0.23
 PCT 0.698 <0.001 65.5 71.0 2.26 0.49
 IL-6 0.522 0.713 75.9 36.4 1.19 0.66
 Score 0.745 <0.001 82.8 63.4 2.26 0.27
Non-surgical patients
 SOFA 0.684 <0.001 71.8 59.7 1.78 0.47
 CRP 0.762 <0.001 91.0 59.7 2.26 0.15
 PCT 0.810 <0.001 75.0 77.4 3.32 0.32
 IL-6 0.503 0.953 68.1 43.3 1.20 0.74
 Score 0.836 <0.001 78.2 77.4 3.46 0.28
Newly hospitalized patients
 SOFA 0.781 <0.001 84.6 66.0 2.49 0.23
 CRP 0.805 <0.001 89.7 66.0 2.64 0.16
 PCT 0.868 <0.001 84.6 80.9 4.42 0.19
 IL-6 0.601 0.101 82.1 44.7 1.48 0.40
 Score 0.896 <0.001 84.6 83.0 4.97 0.19
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Discussion
It is now generally agreed that a single clinical biomarker 
is not acceptable for accurately diagnosing and predicting 
prognosis during sepsis. The aim of this investigation was 
to evaluate the ability of an enhanced bioscore, where 
common clinical biomarkers are combined with other 
clinical laboratory information, to provide a more reli-
able diagnosis and prediction tool for sepsis patients. The 
study combined the most common clinical biomarkers 
for sepsis at ICU admission and clinical scoring methods 
to evaluate the possibility of increasing the accuracy of 
sepsis diagnosis in a general population of a Chinese ICU. 
The results of this study show that when threshold values 
of CRP, PCT and SOFA were taken into consideration by 
calculation of a bioscore value, this could be considered 
a statistically significant predictor for sepsis diagnosis. 
In these cases, the AUC values for the combined param-
eter score were more predictive than any one individual 
marker. Therefore, we consider these methods to have 
value in predicting sepsis.
CRP, PCT and IL-6 are used widely in attempting to 
clinically diagnose sepsis. In keeping with previous pub-
lished data, our results confirm a low diagnostic value of 
CRP in a general ICU population [16]. However, when 
evaluating our entire study population, the accuracy 
of PCT was relatively low compared to previous stud-
ies and improved only slightly after selecting out surgi-
cal patients. In addition, we found that IL-6 suffered low 
diagnostic significance. There have also been contrasting 
results of IL-6 in diagnosing sepsis in the previous work, 
which may have been a result of different baseline patient 
characteristics [17–19].
Since CRP, PCT and IL-6 had been demonstrated to 
be elevated by various conditions without infection, i.e., 
trauma, surgery, burn, pancreatitis [20–22], we decided 
to analyze the subgroup populations [13]. We found a 
low diagnostic value of CRP and PCT in surgical patients 
and a high diagnostic value in non-surgical patients, 
especially in newly admitted patients. Our population 
was similar to the one described by Gibot et  al. [13], 
and the diagnostic value of the previously mentioned 
biomarkers was comparable in their subgroup patients. 
However, we found the value of IL-6 in diagnosing sepsis 
did not change in the subgroup population, indicating 
IL-6 may not be a valuable biomarker for our cohort of 
patients.
Table 3 Univariate and  multivariate associations of  PCT, 
CRP, SOFA score with sepsis
a Cox and Snell R2 was 0.282, and Nagelkerke R2 was 0.389
Marker Univariate Multivariate
OR (95 % CI) P OR (95 % CI) P
Agea 3.171 (1.833, 5.485) <0.001 2.662 (1.382, 5.127) 0.003
Gendera 0.470 (0.285, 0.773) 0.003 0.377 (0.203, 0.701) 0.002
WBC 0.871 (0.540, 1.405) 0.571 0.704 (0.378, 1.311) 0.268
PCT
 0 1.0 (Reference) 1.0 (Reference)
 1a 4.169 (2.158, 8.055) <0.001 3.485 (1.561, 7.780) 0.008
 2 4.345 (2.155, 8.761) <0.001 3.550 (1.467, 8.593) 0.074
 3a 8.369 (3.815, 18.359) <0.001 6.501 (2.326, 18.173) 0.001
CRP
 0 1.0 (Reference) 1.0 (Reference)
 1 3.191 (1.453, 7.011) 0.004 2.491 (0.958, 6.477) 0.061
 2a 7.700 (3.138, 18.894) <0.001 6.795 (2.188, 21.096) 0.001
 3a 8.800 (3.964, 19.537) <0.001 6.593 (2.395, 18.125) <0.001
SOFA 1.204 (1.117, 1.297) <0.001 2.314 (1.260, 14.251) 0.007
IL-6
 0 1.0 (Reference) 1.0 (Reference)
 1 1.691 (0.586, 4.877) 0.331 1.380 (0.343, 5.559) 0.651
 2 1.364 (0.468, 3.976) 0.569 0.639 (0.152, 2.678) 0.540
 3 1.524 (0.526, 4.415) 0.438 0. 576 (0.146, 2.278) 0.432
 4 1.227 (0.425, 3.542) 0.706 0. 422 (0.106, 1.681) 0.221
(See figure on next page.) 
Fig. 2 Diagnostic values for sepsis patients estimated by receiver operating curve (ROC) analysis. a For clinical variables in non-surgically treated 
patients: Area under the curve (AUC) for a null hypothesis was 0.5. AUC for C-reactive protein (CRP) was 0.697 (95 % CI 0.620–0.767, P < 0.001), proc-
alcitonin (PCT) 0.698 (95 % CI 0.620–0.768, P < 0.001), interleukin-6 (IL-6) 0.522 (95 % CI 0.441–0.602, P = 0.713), white blood cells (WBC) 0.525 (95 % 
CI 0.445–0.604, P = 0.676), body temperature 0.511 (95 % CI 0.431–0.591, P = 0.851) and sepsis-related organ failure assessment (SOFA) 0.587 (95 % 
CI 0.507–0.664, P < 0.001). b For calculated score in non-surgically treated patients: Area under the curve (AUC) for a null hypothesis was 0.5. AUC for 
calculated score was 0.745 (95 % CI 0.670–0.810, P < 0.001). c For clinical variables in non-surgically treated patients: Area under the curve (AUC) for 
a null hypothesis was 0.5. AUC for C-reactive protein (CRP) was 0.762 (95 % CI 0.683–0.830, P < 0.001), procalcitonin (PCT) 0.810 (95 % CI 0.734–0.871, 
P < 0.001), interleukin-6 (IL-6) 0.503 (95 % CI 0.415–0.591, P = 0.953), white blood cells (WBC) 0.486 (95 % CI 0.390–0.582, P = 0.775), body tempera-
ture 0.478 (95 % CI 0.382–0.575, P = 0.659) and sepsis-related organ failure assessment (SOFA) 0.684 (95 % CI 0.600–0.769, P < 0.001). d For calcu-
lated score in non-surgically treated patients: Area under the curve (AUC) for a null hypothesis was 0.5. AUC for calculated score was 0.836 (95 % CI 
0.764–0.893, P < 0.001). e For clinical variables in newly hospitalized sepsis patients: Area under the curve (AUC) for a null hypothesis was 0.5. AUC 
for C-reactive protein (CRP) was 0.805 (95 % CI 0.705–0.882, P < 0.001), procalcitonin (PCT) 0.868 (95 % CI 0.778, 0.931, P < 0.001), interleukin-6 (IL-6) 
0.601 (95 % CI 0.490–0.705, P = 0.102), white blood cells (WBC) 0.482 (95 % CI 0.354–0.610, P = 0.774), body temperature 0.505 (95 % CI 0.378–0.632, 
P = 0.940) and sepsis-related organ failure assessment (SOFA) 0.781 (95 % CI 0.679–0.863, P < 0.001). f For calculated score in newly hospitalized 
sepsis patients: Area under the curve (AUC) for a null hypothesis was 0.5. AUC for calculated score was 0.896 (95 % CI 0.812–0.952, P < 0.001)
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Other factors widely assessed in the diagnosis of sep-
sis and determining prognosis are body temperature 
and WBC count. However, these factors have repeatedly 
being shown to have poor sensitivity and specificity for 
sepsis diagnosis [23, 24]. Similarly, we found a low diag-
nostic value of body temperature and WBC count in our 
analysis.
Single parameter measurement had a relatively low 
diagnostic value in sepsis. Therefore, we combined mul-
tiple clinical parameters to build a scoring system to 
improve diagnostic abilities. Recently, Gibot and col-
leagues reported that some relatively new biomarkers 
(PCT, sTREM-1 and PMN CD64 index) were useful for 
diagnosing sepsis and that the combination of them in a 
score had an impressive diagnostic accuracy [13]. How-
ever, as the authors stated, these measurements may not 
be routinely available in all hospitals, limiting the scoring 
systems applicability. In contrast, CRP, PCT and IL-6 are 
available in most of the hospital laboratories, and their 
combination in an easily computable score could improve 
the accuracy of sepsis diagnosis. By analyzing ROC 
curves in this study, we were able to select a cutoff value 
for the bioscore for diagnosis prediction. In each popula-
tion of patients, including the total ICU population, the 
non-surgical subpopulation and the newly hospitalized 
subpopulation, this method provided a better prediction 
of diagnosis than any of the other biomarkers in isolation 
that were assessed in this study, which was similar to pre-
vious published information [13].
The present study has its limitations. First, this is a 
single-center study and the numbers of patients studied 
are limited. A larger population would add more power, 
making the results more generalizable. Different stud-
ies have described different ROC and AUC for the same 
biomarkers. This can be explained by different studied 
populations and laboratory techniques, all of which can 
impact the diagnostic and prognostic power of these 
tests. However, our measurements are consistent with 
the previous literature, validating our results. Second, 
we considered values only at ICU admission and we did 
not analyze trends during the course of stay. For exam-
ple, temperature pattern can be more useful than a single 
value at admission [25, 26]. Moreover, other studies show 
how the trend and modification of biomarkers could be 
helpful to manage antibiotic usage [27], to monitor the 
patient’s recovery from sepsis and to predict the out-
come. Given our aim to measure the value of a compos-
ite of clinical and laboratory data to assist the clinician 
toward making the correct and timely diagnosis of sepsis, 
in order to increase accuracy, we limited our evaluations 
to those at patient admission.
Conclusions
The present study shows a combined PCT, CRP and 
SOFA score, used to calculate a patient bioscore, may be 
a valuable predictive tool to accurately diagnose sepsis.
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Table 4 Univariate and  multivariate analysis of  28-day 
mortality
a Cox and Snell R2 was 0.144, and Nagelkerke R2 was 0.215
Marker Univariate Multivariate
OR (95 % CI) P OR (95 % CI) P
Agea 1.017 (1.001, 1.033) 0.038 1.022 (1.003, 1.041) 0.024
Gender 0.670 (0.389, 1.156) 0.150 0.805 (0.437, 1.485) 0.488
PCT (ng/mL) 0.999 (0.996, 1.003) 0.671 0.997 (0.982, 1.013) 0.720
CRP (mg/L) 1.001 (0.997, 1.005) 0.606 0.999(0.994, 1.004) 0.718
SOFAa 1.261 (1.160, 1.371) <0.001 1.263 (1.148, 1.389) <0.001
IL-6 1.010 (1.001, 1.017) 0.045 1.000 (1.000, 1.001) 0.128
WBC 1.007 (0.997, 1.018) 0.179 1.005 (0.994, 1.004) 0.392
Body tempera-
ture
1.214 (1.002, 1.471) 0.048 1.100 (0.876, 1.381) 0.413
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